CytomX Therapeutics, Inc. (CTMX)
3.79
-0.09
(-2.32%)
USD |
NASDAQ |
May 13, 16:00
3.79
0.00 (0.00%)
After-Hours: 19:03
CytomX Therapeutics Cash from Investing (Quarterly) : -192.78M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | -0.027M |
| Rigel Pharmaceuticals, Inc. | -7.975M |
| Ovid Therapeutics, Inc. | 5.95M |
| Gossamer Bio, Inc. | 73.16M |
| Mirum Pharmaceuticals, Inc. | -11.57M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -25.55M |
| Cash from Financing (Quarterly) | 234.49M |
| Free Cash Flow | -80.19M |
| Free Cash Flow Per Share (Quarterly) | -0.1441 |
| Free Cash Flow to Equity (Quarterly) | -24.16M |
| Free Cash Flow to Firm (Quarterly) | -25.55M |
| Free Cash Flow Yield | -13.19% |